Gemini Investments (Holdings) Valuation
Is 174 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 174 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 174's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 174's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 174?
Key metric: As 174 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 174's PS Ratio? | |
|---|---|
| PS Ratio | 0.1x |
| Sales | HK$1.15b |
| Market Cap | HK$140.46m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 6.2x |
| Enterprise Value/EBITDA | 16.5x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 174's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 3.5x | ||
430 Oriental Explorer Holdings | 5x | n/a | HK$124.2m |
2263 Fu Shek Financial Holdings | 3.8x | n/a | HK$173.0m |
821 Value Convergence Holdings | 1.3x | n/a | HK$94.0m |
397 Minerva Group Holding | 3.7x | n/a | HK$238.0m |
174 Gemini Investments (Holdings) | 0.1x | n/a | HK$140.5m |
Price-To-Sales vs Peers: 174 is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (3.5x).
Price to Sales Ratio vs Industry
How does 174's PS Ratio compare vs other companies in the HK Capital Markets Industry?
| 11 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| Industry Avg. | 3.0x | 12.1% | |
174 Gemini Investments (Holdings) | 0.1x | n/a | US$18.05m |
1461 Zhongtai Futures | 0.3x | n/a | US$77.24m |
985 CST Group | 0.3x | n/a | US$61.24m |
| 11 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
| Industry Avg. | 3.0x | 22.2% | |
174 Gemini Investments (Holdings) | 0.1x | n/a | US$18.05m |
Price-To-Sales vs Industry: 174 is good value based on its Price-To-Sales Ratio (0.1x) compared to the Hong Kong Capital Markets industry average (3.1x).
Price to Sales Ratio vs Fair Ratio
What is 174's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.1x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 174's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
CSSC (Hong Kong) Shipping
HK$10.0b
Operates as a shipyard-affiliated leasing company in People Republic of China, Asia, the United States, and Europe.
3877
HK$1.62
7D
1.9%
1Y
17.4%
Genertec Universal Medical Group
HK$9.0b
Offers financing and advisory services in the People’s Republic of China.
2666
HK$4.78
7D
-1.4%
1Y
14.1%
CSC Financial
HK$211.9b
Provides investment banking services in Mainland China and internationally.
6066
HK$10.66
7D
0%
1Y
37.7%